drugset / Trial / NCT07552389
Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial is a randomized, active controlled, double blind, parallel, multi center, phase 3 study to evaluate the efficacy and safety of monotherapy group of HL1113R1 or HL1113R2 versus HL1113 (Fixed dose combination) in patients with essential hypertension and type II diabetes mellitus
Timeline
- Start
- 2025-12-18
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HL1113R1 | Unknown | — | — |
| Subject | HL1113R2 | Unknown | — | — |
| Subject | HL1113T1 | Unknown | — | — |
| Subject | HL1113T2 | Unknown | — | — |